Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Simon
Joel A
JA
D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D033461:Hyperuricemia / Q000097:blood / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D014528:Uricosuric Agents; D014527:Uric Acid; D013442:Sulfinpyrazone